Clinical Trial Update: Comparative Effectiveness of INTERCEPT Fibrinogen Complex (IFC) and Cryoprecipitate-AHF (Cryo-AHF) for Treatment of Trauma Associated Hemorrhage

View source ↗

Summary

A clinical trial comparing INTERCEPT Fibrinogen Complex (IFC) with Cryoprecipitate-AHF for trauma-associated hemorrhage; recruitment has not yet begun.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypofibrinogenemia
• Traumatic Hemorrhage

Drugs mentioned

• Cryoprecipitate-AHF (cryoprecipitate)
• INTERCEPT Fibrinogen Complex (IFC) (fibrinogen complex)

Snippet

Sponsor: Cerus Corporation | Conditions: Hypofibrinogenemia, Hemorrhage | Status: NOT_YET_RECRUITING